181 related articles for article (PubMed ID: 15063433)
1. Economic analysis of a transesophageal echocardiography-guided approach to cardioversion of patients with atrial fibrillation: the ACUTE economic data at eight weeks.
Klein AL; Murray RD; Becker ER; Culler SD; Weintraub WS; Jasper SE; Lieber EA; Apperson-Hansen C; Heerey AM; Grimm RA;
J Am Coll Cardiol; 2004 Apr; 43(7):1217-24. PubMed ID: 15063433
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: a decision analytic model for patients admitted to the hospital with atrial fibrillation.
Seto TB; Taira DA; Tsevat J; Manning WJ
J Am Coll Cardiol; 1997 Jan; 29(1):122-30. PubMed ID: 8996304
[TBL] [Abstract][Full Text] [Related]
3. Design of a clinical trial for the assessment of cardioversion using transesophageal echocardiography (The ACUTE Multicenter Study). Steering and Publications Committees of the ACUTE Study.
Am J Cardiol; 1998 Apr; 81(7):877-83. PubMed ID: 9555778
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.
Klein AL; Grimm RA; Jasper SE; Murray RD; Apperson-Hansen C; Lieber EA; Black IW; Davidoff R; Erbel R; Halperin JL; Orsinelli DA; Porter TR; Stoddard MF;
Am Heart J; 2006 Feb; 151(2):380-9. PubMed ID: 16442904
[TBL] [Abstract][Full Text] [Related]
5. Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from Assessment of Cardioversion using Transesophageal Echocardiography [ACUTE] II randomized multicenter study).
Zhao L; Zhang Z; Kolm P; Jasper S; Lewis C; Klein A; Weintraub W;
Am J Cardiol; 2008 Feb; 101(3):338-42. PubMed ID: 18237596
[TBL] [Abstract][Full Text] [Related]
6. Transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation: ACUTE trial update.
Asher CR; Klein AL;
Card Electrophysiol Rev; 2003 Dec; 7(4):387-91. PubMed ID: 15071261
[TBL] [Abstract][Full Text] [Related]
7. Cardioversion guided by transesophageal echocardiography: the ACUTE Pilot Study. A randomized, controlled trial. Assessment of Cardioversion Using Transesophageal Echocardiography.
Klein AL; Grimm RA; Black IW; Leung DY; Chung MK; Vaughn SE; Murray RD; Miller DP; Arheart KL
Ann Intern Med; 1997 Feb; 126(3):200-9. PubMed ID: 9027270
[TBL] [Abstract][Full Text] [Related]
8. Post-cardioversion transesophageal echocardiography (POSTEC) strategy with the use of enoxaparin for brief anticoagulation in atrial fibrillation patients: the multicenter POSTEC trial (a pilot study).
Sorino M; Colonna P; De Luca L; Carerj S; Oliva E; De Tommasi SM; Conti U; Iacopi F; D'Agostino C; D'Amato N; Pettinati G; Montericcio V; Cualbu A; De Luca I
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1034-42. PubMed ID: 18163016
[TBL] [Abstract][Full Text] [Related]
9. Impact of cardioversion strategy on functional capacity in patients with atrial fibrillation: the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) study.
Jasper SE; Lieber EA; Murray RD; Apperson-Hansen C; Black IW; Grimm RA; Pape LA; Klein AL;
Am Heart J; 2005 Feb; 149(2):309-15. PubMed ID: 15846270
[TBL] [Abstract][Full Text] [Related]
10. Bleeding complications in patients with atrial fibrillation undergoing cardioversion randomized to transesophageal echocardiographically guided and conventional anticoagulation therapies.
Klein AL; Murray RD; Grimm RA; Li J; Apperson-Hansen C; Jasper SE; Goodman-Bizon AS; Lieber EA; Black IW;
Am J Cardiol; 2003 Jul; 92(2):161-5. PubMed ID: 12860217
[TBL] [Abstract][Full Text] [Related]
11. Cardioversion in patients with atrial fibrillation and left atrial thrombi on initial transesophageal echocardiography: should transesophageal echocardiography be repeated before elective cardioversion? A cost-effectiveness analysis.
Seto TB; Taira DA; Manning WJ
J Am Soc Echocardiogr; 1999 Jun; 12(6):508-16. PubMed ID: 10359923
[TBL] [Abstract][Full Text] [Related]
12. Economic implications of transesophageal echocardiography-guided cardioversion of atrial fibrillation.
Hlatky M; Go AS
J Am Coll Cardiol; 2004 Apr; 43(7):1225-7. PubMed ID: 15063434
[No Abstract] [Full Text] [Related]
13. The use of enoxaparin compared with unfractionated heparin for short-term antithrombotic therapy in atrial fibrillation patients undergoing transoesophageal echocardiography-guided cardioversion: assessment of Cardioversion Using Transoesophageal Echocardiography (ACUTE) II randomized multicentre study.
Klein AL; Jasper SE; Katz WE; Malouf JF; Pape LA; Stoddard MF; Apperson-Hansen C; Lieber EA;
Eur Heart J; 2006 Dec; 27(23):2858-65. PubMed ID: 17098762
[TBL] [Abstract][Full Text] [Related]
14. Potential clinical efficacy and cost benefit of a transesophageal echocardiography-guided low-molecular-weight heparin (enoxaparin) approach to antithrombotic therapy in patients undergoing immediate cardioversion from atrial fibrillation.
Murray RD; Deitcher SR; Shah A; Jasper SE; Bashir M; Grimm RA; Klein AL
J Am Soc Echocardiogr; 2001 Mar; 14(3):200-8. PubMed ID: 11241016
[TBL] [Abstract][Full Text] [Related]
15. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study.
Seidl K; Rameken M; Drögemüller A; Vater M; Brandt A; Schwacke H; Bergmeier C; Zahn R; Senges J
J Am Coll Cardiol; 2002 May; 39(9):1436-42. PubMed ID: 11985904
[TBL] [Abstract][Full Text] [Related]
16. National use of the transesophageal echocardiographic-guided approach to cardioversion for patients in atrial fibrillation.
Murray RD; Goodman AS; Lieber EA; Jasper SE; Grimm RA; Garcia MJ; Miller DM; Klein AL
Am J Cardiol; 2000 Jan; 85(2):239-44. PubMed ID: 10955384
[TBL] [Abstract][Full Text] [Related]
17. A new therapeutic strategy for electrical cardioversion of atrial fibrillation.
de Luca I; Sorino M; Del Salvatore B; de Luca L
Ital Heart J; 2001 Nov; 2(11):831-40. PubMed ID: 11770868
[TBL] [Abstract][Full Text] [Related]
18. Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial.
Kozieł M; Merino JL; De Caterina R; Huber K; Jin J; Melino M; Goette A; Lip GYH;
Eur J Clin Invest; 2020 May; 50(5):e13221. PubMed ID: 32150758
[TBL] [Abstract][Full Text] [Related]
19. Transesophageal echocardiography guided enoxaparin antithrombotic strategy for cardioversion of atrial fibrillation: the ACUTE II pilot study.
Murray RD; Shah A; Jasper SE; Goodman A; Deitcher SR; Katz WE; Malouf JF; Stoddard MF; Grimm RA; Klein AL;
Am Heart J; 2000 Jun; 139(6):E1-7. PubMed ID: 10827367
[TBL] [Abstract][Full Text] [Related]
20. [Atrial fibrillation and cardioversion: role of transesophageal echocardiography].
Moreo A; Mauri F
Ital Heart J Suppl; 2005 Dec; 6(12):780-7. PubMed ID: 16444922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
